Adverse Affect Sample Clauses
The Adverse Affect clause defines circumstances under which a party may take action if an event or change negatively impacts their interests or obligations under the agreement. Typically, this clause outlines what constitutes an 'adverse effect,' such as significant financial loss, regulatory penalties, or operational disruptions, and may require the affected party to notify the other party or allow for renegotiation or termination of the contract. Its core practical function is to allocate risk and provide a mechanism for addressing unforeseen negative developments, ensuring that parties are not unfairly bound by obligations that have become materially detrimental.
POPULAR SAMPLE Copied 1 times
Adverse Affect. Neither this Agreement nor the transactions contemplated hereby, including the assignment to Buyer, by operation of law or otherwise, of any Contract to which Seller is a party, will result in (without any action by Buyer): (i) Buyer granting to any third party any right to or with respect to any Technology owned by, or licensed to, Buyer; (ii) Buyer being bound by, or subject to, any non-compete or other restriction on the operation or scope of its businesses; or (iii) Buyer being obligated to pay any royalties or other amounts to any third party in excess of those payable by Buyer or Seller prior to the Closing. The consummation of the transactions contemplated by this Agreement will neither violate nor result in the breach, modification, cancellation, termination or suspension of Licensed Technology or the loss of, or any adverse effect on, any ownership of any Transferred Technology.
Adverse Affect. The managing underwriter or underwriters of the underwritten offering advises the Company in writing of its view (together with the reasons therefor) that the distribution of all or a specified portion of the Selling Shareholder's Shares concurrently with the Offered Securities by the underwriters will materially and adversely affect the distribution of the Offered Securities by the underwriters; the Company will promptly furnish the Selling Shareholders with a copy of such writing and may, by written notice to the Selling Shareholders accompanying such writing, require that the distribution of all or a specified portion of the Selling Shareholder's Shares be deferred until the completion of the distribution of such securities by the underwriters, but in no event for a period extending beyond the earlier of the 180th day following the effective date of the registration or qualification and the date of expiration of the last to expire lock-up agreement, if any, entered into by any shareholder of the Company at the request of the underwriters.
Adverse Affect. Agent shall not conduct its business in such a manner as to adversely affect the business, good standing or reputation of Company.
Adverse Affect. The issuance and sale of the Securities, the listing and trading of the Securities on the NasdaqCM or the consummation of the transactions contemplated by this Agreement and the Funding Documents, is not and will not be, as of the date hereof or at each Applicable Time, adversely affected by the M&A Rules or any official clarifications, guidance, interpretations or implementation rules in connection with or related to the M&A Rules (collectively, the “M&A Rules and Related Clarifications”).
Adverse Affect. (a) If, after the Shelf Registration Statement or another registration statement contemplating the offer or sale of the Registrable Securities has become effective, ebix advises BRiT in writing that ebix considers it necessary or appropriate for such registration statement to be amended or supplemented in order for sales thereunder to be made in compliance with the rules and regulations of the SEC, then BRiT shall suspend any further sale, transfer or other disposition of its Registrable Securities pursuant to such registration statement until ebix advises BRiT that such registration statement has been amended or supplemented and, as so amended or supplemented has been declared effective by the SEC.
(b) ebix may delay filing any amendment or supplement to the Shelf Registration Statement, and may cause its effectiveness to be delayed, if ebix advises BRiT in such written notice that the filing of such amendment or supplement would (i) adversely affect the negotiation or completion of a material transaction by ebix contemplated at the time the right to delay is exercised or (ii) involve disclosure obligations not in the best interest of ebix, provided that ebix may delay filing any such amendment or supplement to the registration statement and may cause its effectiveness to be delayed for a period not exceeding 60 days from the date of such written notice to BRiT.
(c) The Parties agree that ebix shall have no rights under Section 6.1(b) until January 1, 2002. In addition, the Parties agree that ebix shall not exercise its rights under Section 6.1(b) to the extent such delay would exceed an aggregate of 90 days in any calendar year.